D-1496-2020 Class III Terminated
FDA drug recall D-1496-2020 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Jul 20, 2020 and is designated Class III. Reason for recall: Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity. The recall status is terminated (terminated Jun 20, 2023). Affected quantity: 7632 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 19, 2020
- Initiation Date
- Jul 20, 2020
- Termination Date
- Jun 20, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7632 tubes
Product description
Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.
Reason for recall
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Distribution pattern
Nationwide in the U.S.
Code information
a) AB28353, Exp 12/31/2021; b) AB40178, Exp 12/31/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1496-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026